| 摘要: |
| 目的 为优化完善我国药品注册管理制度提供国际化参考。方法 通过系统总结中国、美国、日本及欧洲药品注册管理制度(监管机构、法律法规及注册程序),对比分析其差异。结果 我国药品注册管理制度在法律法规、审评审批流程及效率、药品监管国际协调等方面还有待于进一步发展提高。结论 全球药品监管呈现科学化、国际化、效率化的发展趋势,建议我国借鉴国际上先进的管理经验,构建更高效权威的药品注册管理制度,为保障公众健康权益和推动医药产业高质量发展提供制度支撑。 |
| 关键词: 药品注册 监管机构 法律法规 注册程序 高效权威 高质量发展 |
| DOI:10.13506/j.cnki.jpr.2025.12.007 |
| 基金项目: |
|
出版日期:2025-12-25
|
|
| Overview and reflections on the drug registration management systems of China, the United States, Japan and European Union |
| DING Xiaoli,LI Mengjiao,TAN Liyuan,YAO Shangchen,CHEN Hua,SUN Huimin |
| (National Institutes for Food and Drug Control, NMPA Key Laboratory for Quality Research and Evaluation of Chemical Drugs, Beijing 102629, China) |
| Abstract: |
| Objective To provide international references for optimizing and improving the drug registration management system of China. Methods The drug registration management systems of China,the United States,Japan and the European Union,were summarized and analyzed systematically, including the regulatory authorities,law and regulations and registration procedures. Results The drug registration management system of China should be implemented in terms of law and regulations、review and approved process and efficiency, inernational coordination. Conclusion Global drug regulation is showing a trend of scientific, international and efficient development. It is suggested that China should build a more efficient and authoritative drug registration management by drawing on the international management experience.which can provide institutional support for safeguarding public health rights and high-quality development of the pharmaceutical industry. |
| Key words: Drug registration Regulatory authorities Law and regulations Registration procedure Efficient and authority High-quality development |